As with all of NIH, the budget for NCATS is based on the fiscal year (FY) appropriation provided by Congress and the President. The process starts with the President’s Budget Request, which is usually released in February. The President's request typically is followed by appropriation hearings by Congress, which result in appropriation bills and reports. The final appropriation bill, if passed by Congress and signed by the President, provides NCATS with its budget for the FY (October 1 through September 30).
NCATS tracks the status of its budget and provides relevant information below. The status of all appropriation bills also is available.
Future Fiscal Year: 2024
On March 9, 2023, the President’s Budget for FY 2024 was released. Additional supporting materials were released on March 13, 2023. The FY 2024 budget request for NIH is $48.6 billion. The FY 2024 budget request for NCATS (PDF – 3.0MB) is $923.3 million. A 2-page NCATS fact sheet (PDF - 1.3MB) is also available.
Current Fiscal Year: 2023
On December 29, 2022, the President signed into law (P.L. 117-328) the “Consolidated Appropriations Act, 2023.” The Act provides the following for NCATS:
National Center for Advancing Translational Sciences
For carrying out section 301 and title IV of the PHS Act with respect to translational sciences, $923,323,000: Provided, That up to $70,000,000 shall be available to implement section 480 of the PHS Act, relating to the Cures Acceleration Network: Provided further, That at least $629,560,000 is provided to the Clinical and Translational Sciences Awards program.
On March 28, 2022, the President’s Budget for FY 2023 was released. The FY 2023 budget request for NIH is $62.5 billion. The FY 2023 budget request for NCATS (PDF – 1.3MB) is $873.7 million. A 2-page NCATS fact sheet (PDF - 607KB) is also available.
NCATS Budget Distribution
This graphic is a representation of the relative size in terms of annual appropriation of NCATS’ four budget activities: Clinical and Translational Science Activities, Reengineering Translational Sciences, Cures Acceleration Network and Rare Diseases Research.